Mostrar el registro sencillo del ítem

dc.contributor.author
Dávila, Belén  
dc.contributor.author
Sánchez, C.  
dc.contributor.author
Fernandez, M.  
dc.contributor.author
Cerecetto, H.  
dc.contributor.author
Lecot, N.  
dc.contributor.author
Cabral, P.  
dc.contributor.author
Glisoni, Romina Julieta  
dc.contributor.author
González, M.  
dc.date.available
2021-01-05T18:11:36Z  
dc.date.issued
2019-08  
dc.identifier.citation
Dávila, Belén; Sánchez, C.; Fernandez, M.; Cerecetto, H.; Lecot, N.; et al.; Selective Hypoxia-Cytotoxin 7-Fluoro-2-Aminophenazine 5,10-Dioxide: Toward Candidate-to-Drug Stage in the Drug-Development Pipeline; Wiley Blackwell Publishing, Inc; ChemistrySelect; 4; 32; 8-2019; 9396-9402  
dc.identifier.issn
2365-6549  
dc.identifier.uri
http://hdl.handle.net/11336/121516  
dc.description.abstract
7-Fluoro-2-aminophenazine 5,10-dioxide, 1, has displayed in vitro bioreductive selective cytotoxicity, which could acts towards tumors containing hypoxic regions. In this work, we describe some preclinical studies of compound 1 confirming its in vivo antitumor activity. The synthesis of compound 1 was scaled up to 3 g improving the micro-scale yield. Some drug-like properties for compound 1 were theoretically-predicted and others, i.e. aqueous-solubility and toxicity -mutagenicity, in vivo chromosomal-aberrations and ip acute LD50-, were experimentally confirmed. Antitumoral activity was studied in mice bearing hypoxic 4T1-breast-tumor by assessing evolution of the tumor sizes, animal-survival and bio-chemical/hematological. Compound 1 in vivo efficacy, with the absence of systemic toxicity, was confirmed. Results highlight the potential of 7-fluoro-2-aminophenazine 5,10-dioxide as promissory therapeutic agentfor solid tumors.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Wiley Blackwell Publishing, Inc  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
PHENAZINE  
dc.subject
ANTITUMORAL CANDIDATE  
dc.subject
IN VIVO PROOF  
dc.subject
BREAST CANCER  
dc.subject.classification
Química Orgánica  
dc.subject.classification
Ciencias Químicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Selective Hypoxia-Cytotoxin 7-Fluoro-2-Aminophenazine 5,10-Dioxide: Toward Candidate-to-Drug Stage in the Drug-Development Pipeline  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-12-17T19:15:26Z  
dc.journal.volume
4  
dc.journal.number
32  
dc.journal.pagination
9396-9402  
dc.journal.pais
Alemania  
dc.description.fil
Fil: Dávila, Belén. Universidad de la República; Uruguay  
dc.description.fil
Fil: Sánchez, C.. Universidad de la República; Uruguay  
dc.description.fil
Fil: Fernandez, M.. Universidad de la República; Uruguay  
dc.description.fil
Fil: Cerecetto, H.. Universidad de la República; Uruguay  
dc.description.fil
Fil: Lecot, N.. Universidad de la República; Uruguay  
dc.description.fil
Fil: Cabral, P.. Universidad de la República; Uruguay  
dc.description.fil
Fil: Glisoni, Romina Julieta. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Nanobiotecnología. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Nanobiotecnología; Argentina  
dc.description.fil
Fil: González, M.. Universidad de la República; Uruguay  
dc.journal.title
ChemistrySelect  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1002/slct.201902601  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/slct.201902601